Drug
Rapid Acting Intramuscular Olanzapine
Rapid Acting Intramuscular Olanzapine: highest development phase Phase 3, developed by Eli Lilly. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| Rapid-Acting Intramuscular Olanzapine NCT00970281 | Phase 3 | Schizophrenia |
Latest
No recent events.
Follow Rapid Acting Intramuscular Olanzapine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.